Home › Funds › M.D. Sass, LLC › NVDA

M.D. Sass, LLC position in NVDA

NVIDIA CORPORATION · Technology

M.D. Sass, LLC reported holding 9,642 shares of NVDA (NVIDIA CORPORATION) in its Q2 2026 13F filing — a position valued at US$1.9M, representing 0.13% of its reported portfolio and ranking #37 among its reported holdings. M.D. Sass, LLC has disclosed NVDA holdings in 7 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)9.64K sh
Reported value held$1.93M
Portfolio Weight0.13%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How M.D. Sass, LLC's NVDA position evolved

M.D. Sass, LLC first disclosed a stake in NVDA in Q3 2023 at 1,650 shares (US$718K). The position peaked in Q4 2024 at 19,831 shares, worth US$2.7M. Across 7 filings, M.D. Sass, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 9,642 shares valued at US$1.9M. Notable position changes include a 900% increase in Q2 2024 (shares fell 2% over the following quarter), a 55% increase in Q3 2024 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.65K $717.73K New
Q4 2023 1.65K $817.11K Hold
Q1 2024 1.33K $1.20M Reduce
Q2 2024 13.30K $1.64M Add
Q3 2024 20.55K $2.50M Add
Q4 2024 19.83K $2.66M Reduce
Q2 2026 9.64K $1.93M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About NVDA and 13F data

NVDA (NVIDIA CORPORATION) is a Technology company. 47 other funds we track also report a position in NVDA — the largest reported positions include Vanguard Group (US$422.74B), VANGUARD CAPITAL MANAGEMENT LLC (US$308.30B), Fidelity Management & Research (FMR) (US$205.30B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding NVDA

All NVDA fund holders →

FAQ

How long has M.D. Sass, LLC held NVDA?

M.D. Sass, LLC has disclosed NVDA holdings in 7 of the last 12 reported quarters, going back to Q3 2023.

What is M.D. Sass, LLC's current position in NVDA?

As of Q2 2026, M.D. Sass, LLC holds 9.64K shares of NVDA (NVIDIA CORPORATION), valued at $1.93M, representing 0.13% of its reported portfolio and ranking #37.

Has M.D. Sass, LLC been buying or selling NVDA?

In the latest 13F filing (Q2 2026), M.D. Sass, LLC newly opened its position in NVDA. The position peaked in Q4 2024 at 19.83K shares.

Which other funds hold NVDA?

Other major institutional holders of NVDA include Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, Fidelity Management & Research (FMR), among 47 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.